Table of Contents Author Guidelines Submit a Manuscript
Journal of Addiction
Volume 2014, Article ID 965267, 5 pages
http://dx.doi.org/10.1155/2014/965267
Research Article

Predictors of Dropout from Inpatient Opioid Detoxification with Buprenorphine: A Chart Review

1Department of Clinical Sciences Lund, Division of Psychiatry, Lund University, Baravägen 1, 221 85 Lund, Sweden
2Malmö Addiction Center, SUS Malmö, Jan Waldenströms Gata 77, 205 02 Malmö, Sweden
3Primary Care Unit, Kumla, Örebro County, Norra Kungsvägen 10, 692 31 Kumla, Sweden

Received 21 June 2014; Revised 29 September 2014; Accepted 1 October 2014; Published 30 October 2014

Academic Editor: Angela L. Stotts

Copyright © 2014 Anders Hakansson and Emma Hallén. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. R. Kosten, B. J. Rounsaville, and H. D. Kleber, “Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts,” American Journal of Drug and Alcohol Abuse, vol. 11, no. 1-2, pp. 1–10, 1985. View at Publisher · View at Google Scholar · View at Scopus
  2. L. San, J. Cami, J. M. Peri, R. Mata, and M. Porta, “Success and failure at inpatient heroin detoxification,” British Journal of Addiction, vol. 84, no. 1, pp. 81–87, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. B. P. Smyth, J. Barry, E. Keenan, and K. Ducray, “Lapse and relapse following inpatient treatment of opiate dependence,” Irish Medical Journal, vol. 103, no. 6, pp. 176–179, 2010. View at Google Scholar · View at Scopus
  4. G. Blennow, A. Fergusson, and A. Medvedeo, “Buprenorfin nytt alternativ för avgiftning av heroinister,” Läkartidningen, vol. 97, no. 15, pp. 1830–1833, 2000. View at Google Scholar
  5. W. Ling, L. Amass, S. Shoptaw et al., “A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network,” Addiction, vol. 100, no. 8, pp. 1090–1100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. A. Marsch, W. K. Bickel, G. J. Badger et al., “Comparison of pharmacological treatments for opioid-dependent adolescents. A randomized controlled trial,” Archives of General Psychiatry, vol. 62, no. 10, pp. 1157–1164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Gowing, R. Ali, and J. White, “Buprenorphine for the management of opioid withdrawal,” Cochrane Database of Systemic Reviews, no. 3, Article ID CD002025, 2009. View at Google Scholar · View at Scopus
  8. A. Hakansson, A. Medvedeo, and M. Berglund, “Prolonged retention in opiate detoxification with buprenorphine (Subutex),” in Proceedings of the Annual Meeting of the Swedish Society of Medicine, 2005.
  9. E. D. Collins, T. Horton, K. Reinke, L. Amass, and E. V. Nunes, “Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation,” Journal of Substance Abuse Treatment, vol. 32, no. 2, pp. 167–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. P. Mattick, J. Kimber, C. Breen, and M. Davoli, “Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence,” The Cochrane Database of Systematic Reviews, no. 2, Article ID CD002207, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. D. Weiss, J. S. Potter, D. A. Fiellin et al., “Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial,” Archives of General Psychiatry, vol. 68, no. 12, pp. 1238–1246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. P. A. DeMaria Jr., R. Sterling, and S. P. Weinstein, “The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment,” The American Journal on Addictions, vol. 9, no. 2, pp. 145–153, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. J. D. Jones, S. Mogali, and S. D. Comer, “Polydrug abuse: a review of opioid and benzodiazepine combination use,” Drug and Alcohol Dependence, vol. 125, no. 1-2, pp. 8–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Pérez de los Cobos, J. Trujols, E. Ribalta, and M. Casas, “Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice,” The American Journal of Drug and Alcohol Abuse, vol. 23, no. 2, pp. 267–279, 1997. View at Publisher · View at Google Scholar · View at Scopus